Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Eminase

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
BACKGROUND QT dispersion (QTd; QT interval maximum minus minimum) has been shown to reflect regional variations in ventricular… Expand
1995
1995
The outcome of patients with Thrombolysis in Myocardial Infarction (TIMI) trial grade 2 flow is worse than that of patients with… Expand
1995
1995
BACKGROUND A double-blind, placebo-controlled study using anistreplase was performed in 159 patients with unstable angina. All… Expand
1994
1994
OBJECTIVES The presence of thrombus formation and type of coronary artery lesion were determined in patients with unstable angina… Expand
Highly Cited
1992
Highly Cited
1992
One measure of the success of thrombolysis is the early patency status of the infarct-related coronary artery. The Thrombolysis… Expand
1991
1991
Interest in early thrombolysis has prompted a study on the feasibility and time course of prehospital thrombolysis in patients… Expand
1991
1991
In this article we report on the development, introduction, and maintenance of a policy to promote rational use of thrombolytic… Expand
Review
1990
Review
1990
  • S. Sherry
  • Clinical cardiology
  • 1990
  • Corpus ID: 11508524
Eminase (anistreplase), or anisoylated plasminogen streptokinase activator complex (APSAC), is a reversibly inactivated lys… Expand
1989
1989
Abstract The hydrolysis of the p-anisoyl group from the active centre of the thrombolytic proenzyme APSAC has been studied in… Expand
1988
1988
Abstract The stability of the novel thrombolytic agent APSAC (anisovlated lys 77 -plasminogen-streptokinase activator complex) in… Expand